Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
FDA Delays Decision On Eli Lilly's Alzheimer Drug
March 08, 2024
The FDA will hold an advisory panel for Lilly's Alzheimer drug donanemab.
Via
Investor's Business Daily
Exposures
Product Safety
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
March 08, 2024
Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by...
Via
Benzinga
The Ludicrous List
March 07, 2024
Essentially the
Via
Talk Markets
3 Stocks Mario Gabelli Is Betting on Big
March 07, 2024
Given his strong track record, investors should pay attention to these three top-notch Mario Gabelli stocks.
Via
InvestorPlace
Eli Lilly's Legal Battle Against Fake Compounded Tirzepatide Products: Bacteria, Impurities Detected
March 07, 2024
Discover Eli Lilly's legal action against fraudulent diabetes medication and weight loss treatments. Learn about impurity levels and bacterial concerns.
Via
Benzinga
Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment
March 04, 2024
Via
Benzinga
The Top 3 ETFs to Buy in March 2024
March 07, 2024
Simplify your investment strategy through these top ETFs to buy, offering an excellent blend of diversification and upside.
Via
InvestorPlace
Topics
ETFs
Insurance Coverage For Weight Loss Drugs - Cigna Unveils Efforts To Limit Health Plans/Employers Spending
March 07, 2024
Evernorth Health Services, a Cigna subsidiary, introduces a financial guarantee in its EncircleRx program offering predictability for employers and health plans. Highlights agreements with Novo Nordisk...
Via
Benzinga
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
March 07, 2024
Explore President Biden's plan to expand Medicare drug negotiations, targeting at least 50 drugs annually. Uncover the impact on pharmaceutical profits and the broader health-care policy proposals,...
Via
Benzinga
Novo Nordisk's Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data
March 07, 2024
Explore Novo Nordisk's Capital Markets Day insights! Uncover early trial success of amycretin, a potential obesity drug, with 13.1% weight loss in Phase 1. Learn about its safety and upcoming Phase 2...
Via
Benzinga
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug
March 07, 2024
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.
Via
Investor's Business Daily
Why Meta Platforms Stock Topped the Market Today
March 06, 2024
Investors were happy that the company had a generally uneventful Wednesday.
Via
The Motley Fool
Trillion-Dollar Threshold: The Next 3 Stocks Ready to Rise
March 06, 2024
With a trillion-dollar valuation in sight, these three growth companies have stocks ready to rise to meet the challenge.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
March 06, 2024
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.
Via
Investor's Business Daily
Exposures
Product Safety
Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk
March 06, 2024
Eli Lilly's strategic collaborations with outsourcing partners for Zepbound (tirzepatide) production. Challenges persist as Eli Lilly and Novo Nordisk address production bottlenecks amid rising...
Via
Benzinga
Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments
March 06, 2024
Beam Therapeutics stock is rising as the company begins to receive significant money from the multiple licensing deals it has in place
Via
MarketBeat
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher
Via
MarketBeat
Exposures
Product Safety
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
March 05, 2024
Eli Lilly and Novo Nordisk dominate the diabetes market thanks to blockbuster medications Mounjaro, Ozempic, and Rybelsus.
Via
The Motley Fool
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
Jim Cramer Says Nvidia, Eli Lilly, Novo Nordisk Are Not Overvalued: 'Will Be Ready To Buy If This Market Sells Off'
March 05, 2024
Cramer suggested that the upcoming labor report could potentially trigger a buying opportunity, predicting stronger figures than expected by Wall Street.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
March 04, 2024
Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.
Via
InvestorPlace
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $1000. Is It a Buy Around $782?
March 04, 2024
There are two big reasons why Eli Lilly stock is as much as 5x more expensive than Pfizer.
Via
The Motley Fool
Here's How Much You'd Have If You Invested $10,000 in Eli Lilly Stock When Billionaire George Soros First Bought It
March 04, 2024
The tricky part would have been to not sell the pharmaceutical giant's shares when Soros did.
Via
The Motley Fool
This Is the Biggest Company Not in the "Magnificent Seven" -- but It Deserves to Be
March 04, 2024
It's in a distinctly different business than the "Magnificent Seven" companies, but it deserves the same attention.
Via
The Motley Fool
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
March 03, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
Via
NewMediaWire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
March 03, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
Via
TheNewswire.com
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.